No experience
Employment Type:
Job Category:
Intern, Business Analyst, CMC
(This job is no longer available)
Agios Pharmaceuticals | Cambridge, MA
Grad Date

Not sure what types of jobs you are interested in?

Explore Jobs
Based on Your Education

Follow This Company

Job Description

Intern, Business Analyst, CMC

Agios (agios.com) is a biopharmaceutical company committed to applying our scientific leadership in cellular metabolism to transform the lives of patients with cancer and rare genetic diseases. We are growing rapidly with an active research and discovery pipeline across both therapeutic areas. Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.

Agios is searching for a dynamic Business Analyst Intern to join our growing CMC (Chemistry, Manufacturing and Controls) team. This individual will be responsible for organizing archived data structure shared externally with development and manufacturing partners and internally among Agios stakeholders. The intern will first understand how the department interacts and shares information with multiple vendors and then structure/organize/templatize the repository to enable project consistency. In addition to this, the Business Analyst Intern will establish work flows for internal data requests.

Key Responsibilities

* Optimize the multiple data repository systems currently employed to enable more efficient knowledge and information sharing

* Generate ideas and implement better approaches to increase project consistency and improve operational efficiency

* Collaborate with groups outside of CMC to develop and implement work flow(s)

Minimum Requirements

* Current student pursuing their undergraduate degree

* Desire to learn and understand how different functions interact

* Exhibit excellent organizational skills

Preferred Qualifications

* Basic understanding of the drug development process

* Familiarity with storage and collaboration systems such as Egnyte and SharePoint

About Agios Pharmaceuticals

Agios is an independent, private biopharmaceutical company at the forefront of drug discovery in one of the most exciting new areas of cancer research: cancer metabolism. The intersection of two fields of research - cancer and metabolism - offers an important and novel approach to treating cancer. Research in cancer metabolism has provided new understandings of fundamental mechanisms behind cancer survival, representing a new, powerful strategy to target this deadly disease. Agios is developing a diverse pipeline of cancer metabolism drug candidates, building on the company's intellectual property and drug discovery platform as well as the unique insights of its founders and scientific advisors. Agios' novel drugs will be targeted therapies directed at modulating key metabolic pathways such as glycolysis (sugar metabolism), fatty acid metabolism, and autophagy (self-metabolism). The company's primary focus is in oncology, though Agios' platform may also be applicable to other therapeutics areas featuring diseases of cellular proliferation, including autoimmune, inflammatory and neurological diseases. Agios has a scientific team that is second to none in the field of cancer metabolism. The company was founded by the core thought leaders who have made key advances and discoveries in the field of cancer metabolism. Agios has attracted and continues to seek out top talent to translate the science of cancer metabolism into transformational drugs for patients.